产品名称 | NebuSelect™ Recombinant Biotinylated Human LRRC15/LIB, Avi-His-tag |
---|---|
目录号 | NBL-240467 |
别名 | LRRC15/LIB; LIB; LRRC15 |
外观 | see COA |
分子量 | Tyr22-Gly538 |
CAS | N/A |
溶解度 | Water Soluble |
存储条件 | Short term 4℃; Long term -20℃. |
保存时间 | 2 years |
备注1 | Q8TF66-1 |
备注2 |
目录号 | 规格 | 价格 | 库存状态 | |
NBL-240467-100ug | 100ug | Inquire | Inquire | |
NBL-240467-1mg | 1mg | Inquire | Inquire | |
NBL-240467-Customized Size | N/A | Inquire | Inquire |
Product Name:
NebuSelect™ Recombinant Biotinylated Human LRRC15/LIB, Avi-His-tag
Catalog#:
NBL-240467
Description:
NebuSelect™ Recombinant Biotinylated Human LRRC15/LIB, Avi-His-tag(Cat#NBL-240467) is expressed in CHO with His tag and Avi tag at the C-Terminus.It contains Tyr22-Gly538.
Species:
Human
Expression System:
CHO
Molecular Weight:
The protein has a predicted MW of 60.7 kDa. Due to glycosylation, the protein migrates to 70-80 kDa based on Bis-Tris PAGE result.
Target Name:
LRRC15/LIB; LIB; LRRC15
Target Information:
The chimeric protein binds in vitro and in vivo to a specific element upstream of LRRC15, leading to dramatic transcriptional activation.- LRRC15 encodes a leucine-rich transmembrane protein, present at the leading edge of migrating cells, the expression of which in normal tissues is restricted to the invasive cytotrophoblast layer of the placenta; small interfering (siRNA)-mediated suppression of LRRC15 expression in breast cancer cells leads to abrogation of invasiveness in vitro.
Amino Acid Sequence:
Tyr22-Gly538
Purity:
>95%
Formulation:
see COA
Endotoxin:
<1EU/ug(LAL Method)
Storage:
4°C for short term.
-20°C for long term.
To get more information, please contact us freely.